Ignite Creation Date:
2025-12-24 @ 12:15 PM
Ignite Modification Date:
2025-12-24 @ 12:15 PM
Study NCT ID:
NCT06804161
Status:
RECRUITING
Last Update Posted:
2025-12-22
First Post:
2025-01-27
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension
Sponsor:
Prof. Dr. med. Ingo Eitel
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12-10
Start Date Type:
ACTUAL
Primary Completion Date:
2032-05-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-05-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-27
First Submit QC Date:
None
Study First Post Date:
2025-02-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-15
Last Update Post Date:
2025-12-22
Last Update Post Date Type:
ESTIMATED